Literature DB >> 3973724

Early operation and overall outcome in aneurysmal subarachnoid hemorrhage.

B Ljunggren, H Säveland, L Brandt, S Zygmunt.   

Abstract

Over a 3-year period, 251 individuals in a population of 1.46 million were known to have suffered an aneurysmal subarachnoid hemorrhage (SAH). Forty-three individuals (17%) were either found dead or were dead on arrival at a hospital or forensic department. Forty-nine patients (20%) were at no stage in their clinical course considered to be surgical candidates. Six patients (2% of the total series) were initially in good condition, but subsequently deteriorated during the acute phase and were not treated surgically. Nineteen poor-risk patients (8% of the total series) underwent emergency surgery because of a life-threatening intracerebral hematoma; 105 patients (42% of the total series or 69% of the surgically treated patients) were operated on at the acute stage, and 29 patients (11% of the total series or 19% of the surgically treated patients) underwent late surgery. Of the total series, 107 patients (42%) recovered without neurological deficits; the overall morbidity rate was 19%, and the mortality rate was 39%. Of 99 Grade I to III patients who were operated on at the acute stage, 76% recovered without neurological deficits, and 4% died. It is concluded that the overall outcome in aneurysmal SAH remains poor, mainly because of the large group of patients who are permanently devastated by their initial bleed.

Entities:  

Mesh:

Year:  1985        PMID: 3973724     DOI: 10.3171/jns.1985.62.4.0547

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  34 in total

Review 1.  Warning leak in subarachnoid haemorrhage.

Authors:  J R Ostergaard
Journal:  BMJ       Date:  1990-07-28

Review 2.  Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine.

Authors:  B Ljunggren; L Brandt; H Säveland; B Romner; T Ryman; K E Andersson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

3.  Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study.

Authors:  N Ross; P J Hutchinson; H Seeley; P J Kirkpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

4.  Acute surgery for intracerebral haematomas caused by rupture of an intracranial arterial aneurysm. A prospective randomized study.

Authors:  O Heiskanen; A Poranen; T Kuurne; S Valtonen; M Kaste
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 5.  Sudden unexplained death in adults caused by intracranial pathology.

Authors:  M Black; D I Graham
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

6.  The use of computed tomography in the prediction of delayed cerebral infarction following acute aneurysm surgery for subarachnoid haemorrhage.

Authors:  Y Hirashima; M Kurimoto; M Takaba; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Management morbidity and mortality in grade IV and V patients with aneurysmal subarachnoid haemorrhage.

Authors:  V Seifert; H A Trost; D Stolke
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

8.  Acute surgery in intracranial aneurysms. Experience with 100 cases.

Authors:  J Bidziński; A Marchel; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

9.  Differences in the management of ruptured intracranial aneurysms: a survey of practice amongst British neurosurgeons.

Authors:  H Marsh; R S Maurice-Williams; K W Lindsay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

10.  Shunt-dependent hydrocephalus after subarachnoid haemorrhage and aneurysm surgery: timing of surgery is not a risk factor.

Authors:  A Tapaninaho; J Hernesniemi; M Vapalahti; M Niskanen; A Kari; M Luukkonen; M Puranen
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.